PRLD · Categories · Form 4

PRLD - SEC Form 4 insider transactions

Prelude Therapeutics Incorporated (PRLD) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PRLD

• 34d
  SEC Form 4 filed by Chief Medical Officer Morris Charles Q

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 40d
  Large owner Ra Capital Management, L.P. disposed of 1,407,000 shares (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 46d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 122d
  SEC Form 4 filed by Chief Chemistry Officer Combs Andrew

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 122d
  SEC Form 4 filed by Chief Scientific Officer Scherle Peggy

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 122d
  SEC Form 4 filed by CLO, CFO, Corp Sec. Lim Bryant David

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 122d
  SEC Form 4 filed by CEO Vaddi Krishna

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 212d
  SEC Form 4 filed by Director Sandor Victor

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 244d
  President, CMO Huang Jane converted options into 9,375 shares and covered exercise/tax liability with 3,355 shares, increasing direct ownership by 7% to 86,917 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 334d
  President, CMO Huang Jane converted options into 9,375 shares and covered exercise/tax liability with 3,355 shares, increasing direct ownership by 8% to 80,897 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 359d
  SEC Form 4 filed by Director Baker Bros. Advisors Lp

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 359d
  SEC Form 4 filed by Director Sandor Victor

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 359d
  SEC Form 4 filed by Director Dier Mardi

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 359d
  SEC Form 4 filed by Director Friedman Paul A

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 359d
  SEC Form 4 filed by Director Bonita David P

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 359d
  SEC Form 4 filed by Director Babler Martin

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 426d
  President, CMO Huang Jane converted options into 9,375 shares and covered exercise/tax liability with 3,355 shares, increasing direct ownership by 9% to 74,877 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 487d
  SEC Form 4 filed by CLO, CFO, Corp Sec. Lim Bryant David

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 487d
  SEC Form 4 filed by Chief Scientific Officer Scherle Peggy

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 487d
  SEC Form 4 filed by Chief Chemistry Officer Combs Andrew

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 487d
  SEC Form 4 filed by President, CMO Huang Jane

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 487d
  SEC Form 4 filed by CEO Vaddi Krishna

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 516d
  President, CMO Huang Jane covered exercise/tax liability with 3,859 shares and converted options into 9,375 shares, increasing direct ownership by 9% to 68,857 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 699d
  President, CMO Huang Jane converted options into 9,375 shares and covered exercise/tax liability with 3,347 shares, increasing direct ownership by 12% to 57,315 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 719d
  SEC Form 4 filed by Director Baker Bros. Advisors Lp

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 719d
  SEC Form 4 filed by Director Sandor Victor

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 719d
  SEC Form 4 filed by Director Friedman Paul A

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 719d
  SEC Form 4 filed by Director Dier Mardi

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 719d
  SEC Form 4 filed by Director Bonita David P

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 719d
  SEC Form 4 filed by Director Babler Martin

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 752d
  SEC Form 4 filed by Lim Bryant David

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 790d
  Huang Jane converted options into 9,375 shares and covered exercise/tax liability with 3,347 shares, increasing direct ownership by 13% to 51,287 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 825d
  SEC Form 4 filed by Lim Bryant David

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 825d
  SEC Form 4 filed by Scherle Peggy

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 825d
  SEC Form 4 filed by Combs Andrew

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 825d
  SEC Form 4 filed by Chardonnet Laurent

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 825d
  SEC Form 4 filed by Huang Jane

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 825d
  SEC Form 4 filed by Vaddi Krishna

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 881d
  Huang Jane converted options into 9,375 shares and covered exercise/tax liability with 3,844 shares, increasing direct ownership by 14% to 45,259 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 907d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 976d
  Huang Jane converted options into 9,375 shares, increasing direct ownership by 31% to 39,728 units (SEC Form 4)

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1067d
  SEC Form 4 filed by Huang Jane

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1082d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1082d
  SEC Form 4 filed by Sandor Victor

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1082d
  SEC Form 4 filed by Friedman Paul A

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1082d
  SEC Form 4 filed by Dier Mardi

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1082d
  SEC Form 4 filed by Bonita David P

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1082d
  SEC Form 4 filed by Babler Martin

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1108d
  SEC Form 4 filed by Vaddi Krishna

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1109d
  SEC Form 4 filed by Lim Bryant David

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1109d
  SEC Form 4 filed by Chardonnet Laurent

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1109d
  SEC Form 4 filed by Vaddi Krishna

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1110d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1110d
  SEC Form 4 filed by Bonita David P

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1110d
  SEC Form 4 filed by Baker Bros. Advisors Lp

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1158d
  SEC Form 4 filed by Huang Jane

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1193d
  SEC Form 4 filed by Lim Bryant David

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1214d
  SEC Form 4 filed by Scherle Peggy

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1214d
  SEC Form 4 filed by Combs Andrew

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1214d
  SEC Form 4 filed by Chardonnet Laurent

  4 - Prelude Therapeutics Inc (0001678660) (Issuer)

Other PRLD categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends